VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ORGOOrganogenesis Holdings Inc.
$2.43$313M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksORGOQuarterly Financials

Organogenesis Holdings Inc. (ORGO) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Organogenesis Holdings Inc. (ORGO) quarterly income statement — complete revenue, gross profit & net income history

ORGO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue37.23M225.07M150.49M100.78M86.69M126.66M115.18M130.23M109.98M99.65M108.53M117.32M
Revenue Growth %-57.06%77.7%30.66%-22.62%-21.17%27.1%6.12%11.01%2.17%-13.73%-7.13%-3.36%
Cost of Goods Sold38.14M49.92M36.25M27.63M23.72M31.05M26.8M29.2M28.7M27.77M25.79M26.32M
COGS % of Revenue102.46%22.18%24.09%27.42%27.36%24.52%23.27%22.42%26.09%27.87%23.76%22.43%
Gross Profit-914K175.15M114.24M73.15M62.97M95.61M88.38M101.04M81.28M71.88M82.74M91M
Gross Margin %-2.46%77.82%75.91%72.58%72.64%75.48%76.73%77.58%73.91%72.13%76.24%77.57%
Gross Profit Growth %-101.45%83.2%29.25%-27.6%-22.53%33%6.82%11.03%0.3%-18.69%-8.76%-3.96%
Operating Expenses64.12M109.92M92.59M83.98M83.15M85.39M82.14M114.93M85.13M73.15M74.69M81.25M
OpEx % of Revenue172.23%48.84%61.52%83.33%95.91%67.42%71.32%88.25%77.41%73.41%68.82%69.26%
Selling, General & Admin65.19M100.17M79.74M73.81M72.51M73.86M71.8M76.54M72.32M61.38M64.22M70.32M
SG&A % of Revenue175.1%44.51%52.99%73.24%83.64%58.31%62.33%58.77%65.76%61.6%59.17%59.94%
Research & Development15.16M10.29M13.22M10.39M10.64M11.53M10.34M15.59M12.81M11.77M10.47M10.94M
R&D % of Revenue40.72%4.57%8.79%10.31%12.27%9.1%8.98%11.97%11.65%11.81%9.65%9.32%
Other Operating Expenses-1000K-536K-377K-226K0001000K0000
Operating Income-65.03M65.23M21.65M-10.83M-20.18M10.22M6.24M-13.89M-3.85M-1.27M8.05M9.74M
Operating Margin %-174.69%28.98%14.39%-10.75%-23.28%8.07%5.42%-10.67%-3.5%-1.27%7.42%8.31%
Operating Income Growth %-222.28%538.31%246.83%22.04%-423.86%905.28%-22.46%-242.56%3.72%-114.56%352.5%-18.35%
EBITDA-52.66M72.24M28.64M-4.17M-13.9M14.67M10.65M-9.69M121K11.03M13.89M13.2M
EBITDA Margin %-141.46%32.1%19.03%-4.14%-16.03%11.58%9.24%-7.44%0.11%11.06%12.8%11.25%
EBITDA Growth %-278.98%392.51%168.98%56.92%-11584.3%33.04%-23.38%-173.41%257.14%-16.94%211.9%-10.09%
D&A (Non-Cash Add-back)12.37M7.01M6.99M6.66M6.28M4.45M4.4M4.2M3.97M12.29M5.84M3.46M
EBIT-65.03M65.23M21.65M-10.83M-20.18M10.19M6.29M-13.92M-3.83M-1.29M8.08M9.77M
Net Interest Income380K0415K669K961K61K-471K-620K-514K-502K-444K-594K
Interest Income380K0415K669K961K0000000
Interest Expense00000-61K471K620K514K502K444K594K
Other Income/Expense-3.44M-1.8M-489K-1M-5.6M34K-419K-648K-491K-527K-413K-566K
Pretax Income-68.47M63.43M21.16M-11.83M-25.78M10.25M5.82M-14.54M-4.34M-1.8M7.64M9.18M
Pretax Margin %-183.93%28.18%14.06%-11.74%-29.74%8.1%5.06%-11.16%-3.95%-1.8%7.04%7.82%
Income Tax-12.31M19.73M-407K-2.44M-6.94M2.58M-6.51M2.5M-2.24M-1.23M4.47M3.86M
Effective Tax Rate %17.98%31.1%-1.92%20.64%26.92%25.16%-111.76%-17.21%51.65%68.37%58.53%42.09%
Net Income-56.16M43.7M21.57M-9.39M-18.84M7.67M12.33M-17.04M-2.1M-568K3.17M5.32M
Net Margin %-150.85%19.42%14.33%-9.32%-21.74%6.06%10.71%-13.09%-1.91%-0.57%2.92%4.53%
Net Income Growth %-198.04%469.53%74.9%44.89%-797.29%1450.88%289.36%-420.6%29.27%-107.59%1373.02%-39.2%
Net Income (Continuing)-56.16M43.7M21.57M-9.39M-18.84M7.67M12.33M-17.04M-2.1M-568K3.17M5.32M
Discontinued Operations000000000000
Minority Interest000000000000
EPS (Diluted)-0.440.270.11-0.10-0.170.040.09-0.13-0.02-0.000.020.04
EPS Growth %-158.82%516.44%19.44%26%-969.18%-288.61%-425%29.65%-107.57%--39.3%
EPS (Basic)-0.440.280.11-0.10-0.170.050.09-0.13-0.02-0.000.020.04
Diluted Shares Outstanding127.8M132.21M130.85M126.85M126.3M132.16M133.93M132.57M131.86M131.86M133.42M133.07M
Basic Shares Outstanding127.8M126.91M126.88M126.85M126.3M131.67M132.58M132.57M131.86M130.92M131.31M131.29M
Dividend Payout Ratio------------